Patents by Inventor Eun Young Byun

Eun Young Byun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190208039
    Abstract: Disclosed herein is a method for transforming data for low volume transmission of a meta model based protocol which monitors power amount data of new renewable energy, including: generating energy sensing data; receiving, by a client, the energy sensing data and transforming the received energy sensing data into meta model data including a meta model and meta data; generating packet meta model data by dividing and compressing the meta model data; transmitting the packet meta model data to a server through an Internet of Things (IOT) communication network; and parsing, by the server, the packet meta model data to output the meta model data.
    Type: Application
    Filed: April 30, 2018
    Publication date: July 4, 2019
    Inventors: Hyun Seung SONG, So Young MOON, Eun Young BYUN, Woo Sung JANG, Bo Kyung PARK, Robert Young Chul KIM
  • Publication number: 20190152973
    Abstract: The present invention relates to a novel heterocyclic derivative compound and a use thereof, and in particular, to a novel heterocyclic derivative compound having selective inhibitory activity for a fibroblast growth factor receptor (FGFR) and a pharmaceutical composition including the same preventing and treating various diseases relating to the FGFR.
    Type: Application
    Filed: June 28, 2017
    Publication date: May 23, 2019
    Applicant: HANMI PHARMACEUTICAL CO., LTD.
    Inventors: Moon Sub LEE, Eun Young BYUN, Ji Sook KIM, Won Jeoung KIM, Nam Du KIM, Seung Hyun JUNG, Young Gil AHN
  • Patent number: 9156852
    Abstract: Provided are a thieno[3,2-d]pyrimidine derivative of formula (I) or a pharmaceutically acceptable salt thereof having inhibitory activity for protein kinase, and a pharmaceutical composition comprising same for prevention and treatment of abnormal cell growth diseases.
    Type: Grant
    Filed: December 27, 2012
    Date of Patent: October 13, 2015
    Assignee: HANMI PHARM. CO., LTD
    Inventors: In Hwan Bae, Jung Beom Son, Sang Mi Han, Eun Joo Kwak, Ho Seok Kim, Ji Young Song, Eun Young Byun, Seung Ah Jun, Young Gil Ahn, Kwee Hyun Suh
  • Publication number: 20140371219
    Abstract: Provided are a thieno[3,2-d]pyrimidine derivative of formula (I) or a pharmaceutically acceptable salt thereof having inhibitory activity for protein kinase, and a pharmaceutical composition comprising same for prevention and treatment of abnormal cell growth diseases.
    Type: Application
    Filed: December 27, 2012
    Publication date: December 18, 2014
    Applicant: HANMI PHARM. CO., LTD
    Inventors: In Hwan Bae, Jung Beom Son, Sang Mi Han, Eun Joo Kwak, Ho Seok Kim, Ji Young Song, Eun Young Byun, Seung Ah Jun, Young Gil Ahn, Kwee Hyun Suh
  • Patent number: 8835458
    Abstract: Provided is a pharmaceutical composition comprising, as an active ingredient, a quinoline or quinazoline derivative of formula (I), a pharmaceutically acceptable salt, an isomer, a hydrate, and a solvate thereof, which is effective in the prevention and treatment of a cancer, inflammation, autoimmune diseases or neurodegenerative disorders which are induced by the overexpression of inhibitor of apoptosis proteins (IAPs).
    Type: Grant
    Filed: August 31, 2011
    Date of Patent: September 16, 2014
    Assignee: Hanmi Science Co., Ltd
    Inventors: In Hwan Bae, Eun Young Byun, Hae Kyoung Ju, Ji Young Song, Seung Hyun Jung, Seung Ah Jun, Ho Seok Kim, Young Hee Jung, Mi Yon Shim, Young Gil Ahn, Maeng Sup Kim
  • Publication number: 20130165386
    Abstract: Provided is a pharmaceutical composition comprising, as an active ingredient, a quinoline or quinazoline derivative of formula (I), a pharmaceutically acceptable salt, an isomer, a hydrate, and a solvate thereof, which is effective in the prevention and treatment of a cancer, inflammation, autoimmune diseases or neurodegenerative disorders which are induced by the overexpression of inhibitor of apoptosis proteins (IAPs).
    Type: Application
    Filed: August 31, 2011
    Publication date: June 27, 2013
    Applicant: HANMI SCIENCE CO., LTD
    Inventors: In Hwan Bae, Eun Young Byun, Hae Kyoung Ju, Ji Young Song, Seung Hyun Jung, Seung Ah Jun, Ho Seok Kim, Young Hee Jung, Mi Yon Shim, Young Gil Ahn, Maeng Sup Kim
  • Patent number: RE47451
    Abstract: Provided are a thieno[3,2-d]pyrimidine derivative of formula (I) or a pharmaceutically acceptable salt thereof having inhibitory activity for protein kinase, and a pharmaceutical composition comprising same for prevention and treatment of abnormal cell growth diseases.
    Type: Grant
    Filed: October 13, 2017
    Date of Patent: June 25, 2019
    Assignee: Hanmi Pharm. Co. Ltd.
    Inventors: In Hwan Bae, Jung Beom Son, Sang Mi Han, Eun Joo Kwak, Ho Seok Kim, Ji Young Song, Eun Young Byun, Seung Ah Jun, Young Gil Ahn, Kwee Hyun Suh